Award: Cancer center
Value: Approximately $2.3 billion
Location: New York City
Client: Memorial Sloan Kettering
A joint venture of Turner Construction and Consigli Construction are on the job for a multibillion-dollar medical project in the Big Apple.
The two firms are working together on the Kenneth C. Griffin Pavilion, a state-of-the-art cancer care facility that will be built at Memorial Sloan Kettering’s main campus in Manhattan, according to a May 26 announcement from the builders. The cost of the project is approximately $2.3 billion, Newsweek reported.
Once complete, the pavilion will contain 12 operating suites and 208 single-occupancy inpatient beds, per New York City-based Turner’s announcement. New York City-based architect CannonDesign lists the facility at 883,000 square feet.
The new pavilion will connect to the main hospital via an enclosed two-story patient bridge over 67th street, Memorial Sloan Kettering’s website says.
The hospital pointed to a projected rise in cancer numbers from the Centers for Disease Control, advancing technology and growing longevity among humans as the impetus for construction.
“Memorial Sloan Kettering Cancer Center provides world-class care and cutting-edge treatment services that make it possible for patients to navigate their cancer journeys with dignity and compassion, and this new facility will equip providers with the resources necessary to meet growing healthcare needs,” said Thomas Drumm, project executive at Milford, Massachusetts-based Consigli, in the news release.
Structural demolition and excavation have already begun, according to a Memorial Sloan Kettering timeline. Steel erection will begin mid-2027, and the facility has a targeted completion date of mid-2030.
“The Kenneth C. Griffin Pavilion at MSK combines advanced technology, thoughtful design, and a patient-centered approach,” said Jason Tavarez, project executive for Turner, in the release. “Together with our joint venture partner, we are committed to delivering this project safely and efficiently while ensuring the hospital remains fully operational throughout construction.”
Other facilities dedicated to studying or treating cancer are also taking shape. In January, Santa Clara, California-based DPR Construction broke ground on Sutter Health’s Advanced Cancer Center and Care Complex in Modesto, California.
Then, in May, Providence, Rhode Island-based Gilbane Building Co. broke ground on the Bellwether Laboratory, a manufacturing facility in Philadelphia dedicated to radioactive molecules used to treat advanced cancers.
